NO991382L - Mellomprodukter og fremgangsmÕte for fremstilling av olanzapin - Google Patents

Mellomprodukter og fremgangsmÕte for fremstilling av olanzapin

Info

Publication number
NO991382L
NO991382L NO991382A NO991382A NO991382L NO 991382 L NO991382 L NO 991382L NO 991382 A NO991382 A NO 991382A NO 991382 A NO991382 A NO 991382A NO 991382 L NO991382 L NO 991382L
Authority
NO
Norway
Prior art keywords
olanzapine
intermediates
preparation
Prior art date
Application number
NO991382A
Other languages
English (en)
Other versions
NO323980B1 (no
NO991382D0 (no
Inventor
Charles A Bunnell
Samuel D Larsen
John R Nichols
Susan M Reutzel
Gregory A Stephenson
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21832120&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO991382(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO991382L publication Critical patent/NO991382L/no
Publication of NO991382D0 publication Critical patent/NO991382D0/no
Publication of NO323980B1 publication Critical patent/NO323980B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO19991382A 1996-09-23 1999-03-22 Krystallinsk dihydrat B eller E olanzapin, fremgangsmate for fremstilling av Form II olanzapin samt preparat NO323980B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2648796P 1996-09-23 1996-09-23
PCT/US1997/016499 WO1998012199A1 (en) 1996-09-23 1997-09-18 Intermediates and process for preparing olanzapine

Publications (3)

Publication Number Publication Date
NO991382L true NO991382L (no) 1999-03-22
NO991382D0 NO991382D0 (no) 1999-03-22
NO323980B1 NO323980B1 (no) 2007-07-30

Family

ID=21832120

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19991382A NO323980B1 (no) 1996-09-23 1999-03-22 Krystallinsk dihydrat B eller E olanzapin, fremgangsmate for fremstilling av Form II olanzapin samt preparat

Country Status (36)

Country Link
US (1) US6020487A (no)
EP (1) EP0831098B1 (no)
JP (2) JP2001500877A (no)
KR (1) KR100560015B1 (no)
CN (1) CN1122036C (no)
AR (1) AR013838A1 (no)
AT (1) ATE209208T1 (no)
AU (1) AU719441B2 (no)
BR (1) BR9712100A (no)
CA (1) CA2265712C (no)
CO (1) CO4910140A1 (no)
CZ (1) CZ299248B6 (no)
DE (1) DE69708428T2 (no)
DK (1) DK0831098T3 (no)
EA (1) EA001642B1 (no)
EG (1) EG23861A (no)
ES (1) ES2166051T3 (no)
HK (1) HK1009807A1 (no)
HU (1) HU226484B1 (no)
ID (1) ID27275A (no)
IL (1) IL128962A (no)
IN (1) IN187156B (no)
MY (1) MY125565A (no)
NO (1) NO323980B1 (no)
NZ (1) NZ334448A (no)
PE (1) PE110398A1 (no)
PL (3) PL196069B1 (no)
PT (1) PT831098E (no)
RS (1) RS49598B (no)
SI (1) SI0831098T1 (no)
SV (1) SV1997000081A (no)
TR (1) TR199900640T2 (no)
TW (1) TW470746B (no)
UA (1) UA59371C2 (no)
WO (1) WO1998012199A1 (no)
ZA (1) ZA978515B (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004507548A (ja) * 2000-08-31 2004-03-11 ドクター・レディーズ・ラボラトリーズ・リミテッド オランザピン水和物の調製方法、及びこれを結晶形態のオランザピンに変換する方法
US6740753B2 (en) 2001-01-04 2004-05-25 Geneva Pharmaceuticals, Inc. Olanzapine crystal modification
AU2002340328A1 (en) * 2001-10-29 2003-05-12 Janet I. Cord Olanzapine dihydrate-ii a process for its preparation and use thereof
WO2003055438A2 (en) 2001-12-24 2003-07-10 Sun Pharmaceutical Industries Limited Crystalline form i of 2-methyl-4-(4-methyl-1-piperazinyl) 10h thieno [2,3-b][1,5]benzodiazepine
AU2003243153A1 (en) * 2002-04-23 2003-11-10 Dr. Reddy's Laboratories Limited Novel crystalline polymorph form-vi of olanzapine and a process for preparation thereof
US7297789B2 (en) 2002-05-31 2007-11-20 Sandoz, Inc. Process of preparation of olanzapine form I
SI21270A (sl) 2002-07-15 2004-02-29 Krka, Tovarna Zdravil, D.D., Novo Mesto Kristalne oblike olanzapina in postopki za njihovo pripravo
EP1575962A1 (en) * 2002-12-24 2005-09-21 Teva Pharmaceutical Industries Limited Novel crystal forms of olanzapine, methods for their preparation and method for the preparation of known olanzapine crystal forms
US20070148218A1 (en) * 2003-11-18 2007-06-28 Gordon Ryan D Olanzapine containing transdermal drug delivery compositions
DE602004014264D1 (de) * 2003-12-22 2008-07-17 Teva Pharma Verfahren zur herstellung von olanzapin
WO2005070938A1 (en) 2004-01-27 2005-08-04 Synthon B.V. Stable salts of olanzapine
US20070072845A1 (en) * 2004-02-19 2007-03-29 Davuluri Rammohan Rao Process for the preparation of olanzapine form 1 useful as antipsychotic drug
EP1781666A1 (en) * 2004-07-14 2007-05-09 Shasun Chemicals and Drugs Limited Improved process for making form i of olanzapine.
ES2253091B1 (es) 2004-07-27 2007-02-01 Inke, S.A. Solvato mixto de olanzapina, procedimiento para su obtencion y procedimiento de obtencion de la forma i de olanzapina a partir del mismo.
WO2006027800A1 (en) * 2004-09-06 2006-03-16 Shasun Chemicals And Drugs Limited A novel process for preparation of a pharmaceutically pure polymorphic form 1 of olanzapine
JP5324098B2 (ja) * 2004-11-16 2013-10-23 アルケルメス ファーマ アイルランド リミテッド 注射可能なナノ粒子のオランザピン製剤
US7834176B2 (en) 2006-01-26 2010-11-16 Sandoz Ag Polymorph E of Olanzapine and preparation of anhydrous non-solvated crystalline polymorphic Form I of 2-methyl-4(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] benzodiazepine (Olanzapine Form I) from the polymorphic Olanzapine Form E
CA2591644A1 (en) * 2007-06-14 2008-12-14 Apotex Pharmachem Inc. Novel processes to form-i of olanzapine
EP2486913A1 (en) 2011-02-14 2012-08-15 Labtec GmbH Rapidly disintegrating oral film formulation for Olanzapin
JP6008734B2 (ja) * 2012-12-20 2016-10-19 株式会社トクヤマ オランザピンｉｉ型結晶の製造方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5302716A (en) * 1986-01-16 1994-04-12 Schering Corporation Fused benzazepines
CA2002596A1 (en) * 1988-11-14 1990-05-14 Thomas M. Eckrich Hydrates of b-lactam antibiotic
US5229382A (en) * 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
GB9009229D0 (en) * 1990-04-25 1990-06-20 Lilly Industries Ltd Pharmaceutical compounds
DE69329887T2 (de) * 1992-05-29 2001-05-23 Eli Lilly And Co., Ltd. Thienobenzodiazepinderivate zur Behandlung von Störungen des Zentralnervensystems
US5550231A (en) * 1993-06-15 1996-08-27 Eli Lilly And Company Loracarbef hydrochloride C1-C3 alcohol solvates and uses thereof
US5602124A (en) * 1994-12-12 1997-02-11 Allelix Biopharmaceuticals, Inc. 5-HT2 receptor ligands
EG24221A (en) * 1995-03-24 2008-11-10 Lilly Co Eli Process for preparing olanzapine
EG23659A (en) * 1995-03-24 2007-03-26 Lilly Co Eli Process and crystal forms of methyl-thieno-benzodiazepine
US5637584A (en) * 1995-03-24 1997-06-10 Eli Lilly And Company Solvate of olanzapine
US5631250A (en) * 1995-03-24 1997-05-20 Eli Lilly And Company Process and solvate of 2-methyl-thieno-benzodiazepine
UA56184C2 (uk) * 1996-09-23 2003-05-15 Елі Ліллі Енд Компані Поліморфна модифікація оланзапіну дигідрату d, фармацевтична композиція та спосіб лікування психотичного стану

Also Published As

Publication number Publication date
EP0831098A2 (en) 1998-03-25
ID27275A (id) 2001-03-22
HU226484B1 (en) 2009-03-02
RS49598B (sr) 2007-06-04
SI0831098T1 (en) 2002-04-30
IL128962A (en) 2003-01-12
TW470746B (en) 2002-01-01
ATE209208T1 (de) 2001-12-15
DK0831098T3 (da) 2002-05-21
DE69708428D1 (de) 2002-01-03
EP0831098A3 (en) 1998-04-29
CA2265712A1 (en) 1998-03-26
PL196068B1 (pl) 2007-12-31
YU15599A (sh) 2001-12-26
ZA978515B (en) 1999-03-23
EP0831098B1 (en) 2001-11-21
BR9712100A (pt) 1999-08-31
AU4484197A (en) 1998-04-14
EA001642B1 (ru) 2001-06-25
IN187156B (no) 2002-02-16
JP2001500877A (ja) 2001-01-23
CN1122036C (zh) 2003-09-24
KR20000048520A (ko) 2000-07-25
US6020487A (en) 2000-02-01
MY125565A (en) 2006-08-30
EG23861A (en) 2007-11-18
CA2265712C (en) 2006-10-31
KR100560015B1 (ko) 2006-03-15
PL196069B1 (pl) 2007-12-31
CZ99099A3 (cs) 1999-11-17
HUP0000066A2 (hu) 2000-06-28
HK1009807A1 (en) 1999-06-11
NO323980B1 (no) 2007-07-30
PT831098E (pt) 2002-04-29
ES2166051T3 (es) 2002-04-01
AR013838A1 (es) 2001-01-31
AU719441B2 (en) 2000-05-11
HUP0000066A3 (en) 2000-11-28
TR199900640T2 (xx) 1999-06-21
PE110398A1 (es) 1999-01-14
PL194565B1 (pl) 2007-06-29
CN1234802A (zh) 1999-11-10
NZ334448A (en) 2000-08-25
WO1998012199A1 (en) 1998-03-26
EA199900326A1 (ru) 1999-08-26
DE69708428T2 (de) 2002-07-04
JP2009242407A (ja) 2009-10-22
NO991382D0 (no) 1999-03-22
CZ299248B6 (cs) 2008-05-28
CO4910140A1 (es) 2000-04-24
UA59371C2 (uk) 2003-09-15
PL332482A1 (en) 1999-09-13
IL128962A0 (en) 2000-02-17
SV1997000081A (es) 1999-01-14

Similar Documents

Publication Publication Date Title
NO991382D0 (no) Mellomprodukter og fremgangsmÕte for fremstilling av olanzapin
NO961006D0 (no) Fosfonomononukleinsyrer, fremgangsmåter for fremstilling derav og anvendelse av forbindelsene
NO305833B1 (no) Naftylforbindelser, mellomprodukter og anvendelse av forbindelsene
NO20012963L (no) Fremgangsmåte for fremstilling av 3-alkanoylindoler og 3- alkylindoler
NO20015542L (no) Fremgangsmåte for fremstilling og anvendelse av N- desmetylzopikloner
NO990432D0 (no) FremgangsmÕte for fremstilling av aminer og aminonitriler
PT829205E (pt) Producao de condimento
IS4980A (is) Aðferðir og milliefni við framleiðslu á setnum krómanól afleiðum
NO994505D0 (no) Forbedret fremgangsmÕte for fremstilling av tiazolidindioner og nye tiazolidindioner
EE03438B1 (et) Felodipiini valmistamise protsess
HUP9600320A3 (en) Process and new intermediates for the preparation of triazolinon-derivatives
NO20002873D0 (no) FremgangsmÕte for økning av produksjonen og forbedring av kvaliteten til sæd
ID18300A (id) Metoda penemperan
NO20012099D0 (no) Fremgangsmåte for fremstilling av 4-arylpiperidin-3- carbinoler og beslektede forbindelser
NO960766D0 (no) Nytt protein og fremgangsmåte for fremstilling av dette
NO990018D0 (no) Belegg og fremgangsmÕte for fremstilling derav
NO971419L (no) Fremgangsmåte for fremstilling av 1,3-alkendioler og 3-hydroksyaldehyder
ID19799A (id) Proses pembuatan paklitaksel
NO990185D0 (no) FremgangsmÕte for fremstilling av naftypyridoner og mellomprodukter
EE200100333A (et) Meetod 2-halo-3-nitro-4-aminopüridiini valmistamiseks ja selleks vajalike vaheühendite saamine
EE200000357A (et) Meetod 16ß-arüüloksü-4-asasteroidide valmistamiseks ning vaheühendid
DK0747365T3 (da) Fremgangsmåde og mellemprodukter til fremstilling af
NO302352B1 (no) Apparat og fremgangsmåte for fremstilling av flerforpakninger
NO20002476D0 (no) FremgangsmÕte for fremstilling av formylimidazoler
FI960790A0 (fi) Menetelmä fluoreenibisfenolin valmistamiseksi

Legal Events

Date Code Title Description
MK1K Patent expired